Gene: CEP20
Official Full Name: centrosomal protein 20provided by HGNC
Gene Summary: Enables identical protein binding activity. Involved in cilium assembly. Located in centriolar satellite and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28645 | CEP20 Knockout cell line (HeLa) | Human | CEP20 | 1:3~1:6 | Negative | Online Inquiry |
KO28646 | CEP20 Knockout cell line (HCT 116) | Human | CEP20 | 1:2~1:4 | Negative | Online Inquiry |
KO28647 | CEP20 Knockout cell line (HEK293) | Human | CEP20 | 1:3~1:6 | Negative | Online Inquiry |
KO28648 | CEP20 Knockout cell line (A549) | Human | CEP20 | 1:3~1:4 | Negative | Online Inquiry |
CEP20 Gene Knockout Cell Lines are a genetically modified tool specifically designed for the study of the CEP20 gene's role in cellular processes. These cell lines are engineered to have a complete knockdown of the CEP20 gene, which encodes a protein involved in the regulation of cell cycle progression and has been implicated in various human diseases, including certain cancers. By creating a model in which the expression of CEP20 is eliminated, researchers can explore its biological functions and the molecular pathways influenced by its absence.
The key function of CEP20 Gene Knockout Cell Lines lies in their ability to elucidate the mechanisms underlying cellular proliferation, differentiation, and response to environmental stimuli. The knockout of the CEP20 gene disrupts these pathways, allowing scientists to observe phenotypic changes and alterations in gene expression profiles, thereby providing insights into its role in pathophysiology.
From a scientific standpoint, these cell lines are invaluable for applications such as drug development, gene therapy research, and the study of disease mechanisms. They serve as a platform for testing potential therapeutic agents aimed at modulating the pathways regulated by CEP20, facilitating advancements in targeted treatment strategies for cancer and other related disorders.
One of the significant advantages of CEP20 Gene Knockout Cell Lines over traditional models is their precise genetic alteration, which minimizes off-target effects that can confound results. Furthermore, these cell lines are readily available for commercialization, ensuring swift integration into ongoing research projects without the extensive time frame associated with developing custom models.
For researchers and clinicians, the ability to work with a specific, validated knockout line enables more robust and reproducible results in experimental setups. This targeted tool not only enriches the research arsenal but accelerates the pace of discovery in genetics and molecular biology.
Our company specializes in high-quality biological products with a commitment to advancing scientific inquiry. With expertise in genetic engineering and a thorough understanding of cellular biology, we offer a range of innovative tools like the CEP20 Gene Knockout Cell Lines, supporting researchers and clinicians in their quest for novel solutions to complex biological questions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.